A detailed history of Clough Capital Partners L P transactions in Arcellx, Inc. stock. As of the latest transaction made, Clough Capital Partners L P holds 4,800 shares of ACLX stock, worth $409,824. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,800
Holding current value
$409,824
% of portfolio
0.03%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$49.74 - $66.98 $238,752 - $321,504
4,800 New
4,800 $264,000
Q3 2023

Nov 14, 2023

SELL
$31.51 - $37.4 $97,681 - $115,940
-3,100 Reduced 2.93%
102,762 $3.69 Million
Q2 2023

Aug 14, 2023

SELL
$27.49 - $46.9 $2.52 Million - $4.3 Million
-91,616 Reduced 46.39%
105,862 $3.35 Million
Q1 2023

May 15, 2023

SELL
$26.92 - $33.94 $1.06 Million - $1.34 Million
-39,500 Reduced 16.67%
197,478 $6.08 Million
Q4 2022

Feb 14, 2023

SELL
$17.18 - $33.0 $8.88 Million - $17.1 Million
-516,855 Reduced 68.56%
236,978 $7.34 Million
Q3 2022

Nov 14, 2022

SELL
$16.67 - $22.04 $6.86 Million - $9.07 Million
-411,700 Reduced 35.32%
753,833 $14.1 Million
Q2 2022

Aug 16, 2022

SELL
$7.21 - $24.43 $319,713 - $1.08 Million
-44,343 Reduced 3.67%
1,165,533 $21 Million
Q1 2022

May 16, 2022

BUY
$12.97 - $19.14 $15.7 Million - $23.2 Million
1,209,876 New
1,209,876 $16.6 Million

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.74B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.